News

One quarter into 2025, CVS Health ( CVS ) has gained the most of any stock in the S&P 500 , with a share price that has popped 50% since the start of the year.

Much of CVS’s gains came leading up to and immediately after the company’s fourth-quarter results in February, when the health insurance and pharmacy giant reported better-than-expected revenue and adjusted earnings per share (EPS) . The strong results may have fueled investors’ hopes of a turnaround under new CEO David Joyner , who assumed the job in October.

CVS Stock Remains Down From Year Ago

Despite its strong start to the year, CVS stock is still below where it was a year ago. Shares of the company lost more than 40% in 2024 amid a difficult year of sales at its pharmacies and higher medical costs in its health insurance division. Reports in October suggested the company was considering separating its pharmacies and Aetna health insurance operations.

Looking ahead, the analyst consensus price target for CVS stock is about $73, according to Visible Alpha. That's about 8% above its closing price of $67.75 on Monday. Of 13 analysts who follow CVS and are tracked by Visible Alpha, 11 have a "buy" or equivalent rating for the stock.

Read the original article on Investopedia